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D27−264 CFTR, rescues both trafﬁcking and chloride channel
function of DF508 CFTR
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In previous studies we showed that transcomplementation of DF508 by truncated
CFTR allows DF508 to progress to the cell surface. Here we study whether D27–
264 CFTR which is missing the ﬁrst 4 transmembrane segments can also rescue
DF508 chloride channel function. Whole cell currents were recorded from CHO
cells expressing wt, DF508, D27–264, or both D27–264 and DF508 CFTR. Currents
were activated by cpt-cAMP and Forskolin. Importantly no current was generated
from unrescued DF508 alone, or from D27–264 alone. Only when both were added
did we observe signiﬁcant whole cell currents which reached to a level near to that
of wtCFTR. The currents measured only when both are cotransfected could have
originated from either from DF508 or D27–264 CFTR. To determine which one
generated the currents, we utilized a CFTR conduction mutant, S341A, which alters
the conductance of CFTR. S341A/ wtCFTR showed drastically reduced currents
even though the protein was highly expressed. When we studied the double mutant,
S341A/DF508 we noted expression of B band but no detectable chloride currents.
When we cotransfected S341A /DF508 with D27–264 CFTR we did detect CFTR
protein but the choride currents were dramatically reduced showing that the currents
observed when DF508 and D27–264 CFTR are cotransfected were generated by
rescued DF508. Immunoprecipitation studies showed that D27–264 can bind to
DF508 CFTR. Our data show that transcomplementation with D27–264 can rescue
both trafﬁcking and chloride channel function of DF508 CFTR most likely via a
bimolecular interaction.
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MicroRNAs (miRNAs) have emerged as a new class of regulators in diverse
biological and pathological processes; however, their role in cystic ﬁbrosis (CF)
lung disease is poorly understood. To study the potential role of miRNAs in the
in vivo pathogenesis of CF-like lung disease we performed miRNA array analysis
(miChip) in lung tissue of bENaC-Tg mice and wild type littermate controls.
Differentially expressed miRNAs were validated by quantitative real-time PCR
and their functional relevance was determined by bioinformatics analysis and in
luciferase reporter assays. Tissue speciﬁc localization of candidate miRNAs was
performed by in situ hybridization.
We demonstrate that miR-148b is upregulated in the lungs from bENaC-Tg
compared to wild type mice. In situ hybridization showed that miR-148b is
predominantly expressed and localized in the conducting airways. Bioinformatics
analysis and luciferase assay in Hela cells suggest Mig-6 (mitogen inducible gene-6)
as a potential target of miR-148b, a protein previously shown in normal lung
development.
Our results suggest that miR-148b may be implicated in pathogenesis of CF lung
disease and may serve as a novel therapeutic target.
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